Searched for
INDIAN MEDICINES PHARMACEUTICALS CORPORATION LTD
Passenger’s suitcase taken by bus conductor kept inside bus diggy, luggage went missing during journey; court orders Rs 43,000 payoutA passenger travelling from Delhi to Dehradun lost a suitcase containing jewellery, clothes and medicines after handing it to a bus conduct...- Protect patients and patents smartlyThe Kerala High Court has stressed the importance of making cancer medicines like ribociclib more affordable for patients. The Government o...
- Modi govt’s 13 strategic disinvestments in 10 yearsThe Modi government is set to sell a 60.72% stake in IDBI Bank for ₹52,878 crore. This sale will surpass previous disinvestment efforts, ma...
- Centre set to cross Rs 80000 cr disinvestment target for first time since FY19 after IDBI Bank stake saleThe Indian government is expected to surpass its budgeted disinvestment target of Rs 80,000 crore for FY27. A significant contributor will ...
- Biocon founder Kiran Mazumdar Shaw says India must shift pharma industry from generics to innovation-led growthKiran Mazumdar-Shaw emphasized the importance of building an innovation-driven pharmaceutical industry in India. She highlighted the need f...
- India, America expanding cooperation across sectors: US ambassador Sergio GorKolkata and the United States are strengthening ties across sectors such as defence, IT, and healthcare. Recent military exercises involvin...
- Panel to finalise cancer drugs for 30% trade margin cap; Rs 2,500 crore annual savings possibleAn expert group is finalizing the list of cancer medicines for a new trade margin cap. The government plans to implement a 30% cap to reduc...
- SC asks govt to broaden inflated pricing review beyond oncologyThe Supreme Court has asked the government to address high markups on medicines and medical devices. The court questioned the decision to l...
- Supreme Court questions govt over drug pricing, asks why cap limited to anti-cancer medicinesThe Supreme Court expressed its worry over the government's restriction of price control measures to only anti-cancer drugs, questioning wh...
- Indian pharma's risk aversion holding back innovation: Kiran Mazumdar-ShawBiocon chairperson Kiran Mazumdar-Shaw calls for greater use of digital technology to speed up drug development, as industry leaders push f...
- Maharashtra to soon introduce digital system for milk tracking to curb adulteration: FDA chiefMaharashtra Food and Drug Administration plans to introduce a digital system to trace milk production. This initiative aims to reduce adult...
- National Formulary of India lists drugs not approved by CDSCO, DCGI seeks explanation from IPCThe National Formulary of India released its latest edition amidst concerns regarding unapproved drugs included in it. The Drug Controller ...
- Health ministry proposes curbs on prescription drug ads by retailers, wholesalers and distributorsThe union health ministry has proposed extending advertising restrictions on prescription drugs to retailers and distributors. This change ...
- Pharmacies, drug distributors may need approval to advertise prescription medicinesThe Union health ministry aims to restrict advertising of prescription drugs by retailers and distributors, requiring prior government appr...
- Cancer drugs may get up to 70% cheaper as govt fixes trade margins on non-scheduled medicines at 30%The government is aiming to cap trade margins on anti-cancer medications at 30%. An expert committee has been tasked with compiling a repor...
- CPHI Milan: Beyond generics, how Indian pharma is rewriting its global playbookAt CPHI Milan, Indian pharma players are looking beyond traditional exports, using partnerships, licensing, CDMO, and differentiated produc...
- Supreme Court seeks committee to curb pharma firms’ unethical marketing practicesThe Supreme Court has directed the government to form a committee regarding pharmaceutical marketing regulations. This follows concerns ove...
- When nothing is cheap, winners may come from any corner: 19 stocks with downside to upside potential of -28% to plus 22%Because each pharma company took a different road, they no longer rise and fall together. Where any one of them stands in 10 years depends ...
- Indian companies must invest in R&D, move from generics to innovation-led industry: Pharma leadersIndian pharmaceutical leaders emphasize the need for investment in innovation to transition from generics to innovative products. They high...
- Indonesia's mandatory halal rules may raise compliance burden for Indian exporters: GTRIOn October 17, Indonesia’s new halal-certification policies will take effect, significantly influencing Indian exporters across sectors. En...
Load More
